Home › All Companies › COSM › Annual Report

Cosmos Health Inc. (COSM) — Annual Report

AI-Powered SEC Filing Analysis

← All COSM filings
Latest Annual Report Filed: 2026-04-15

Key Insights

  • Cosmos Health's revenue increased by 16.6% year-over-year in fiscal 2025, driven by growth in its pharmaceutical and nutraceutical segments.
  • The company's gross margin improved by 2.5 percentage points in fiscal 2025, indicating improved operational efficiency.
  • Cosmos Health issued $6 million in convertible notes in August 2025, which may provide additional capital to fund growth initiatives.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-04-15. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Cosmos Health Inc.

Current Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.